EConsent In Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Platform (Cloud-based, Web-based), By Enrollment Type (On-site, Remote), By Form Type ( General Consent, General Consent with Specific Denial(s), General Denial with Specific Consent(s), General Denial), By Region & Competition, 2021-2031F

May 2026 | 180 pages | ID: EA537EE20910EN
TechSci Research

Abstracts

The Global EConsent In Healthcare Market is anticipated to expand significantly, rising from USD 372.89 Million in 2025 to USD 743.54 Million by 2031, demonstrating a robust CAGR of 12.19%. This market encompasses digital platforms that modernize the informed consent process in healthcare through multimedia and electronic signatures, educating patients and securing their voluntary involvement in clinical trials. Key growth catalysts include the urgent demand for patient-centric trial designs and growing regulatory support for decentralized clinical trials, which require remote enrollment features. Industry confidence in technology's positive impact is high, with 73% of clinical research professionals in 2025 expecting technology providers to drive significant improvements over the next decade, underscoring the vital role of digital solutions in optimizing study operations and ensuring data compliance. However, a major impediment to market growth is the technical challenge of integrating eConsent systems with existing research site infrastructures, as poor interoperability with legacy electronic health record systems often leads to data silos and increased administrative workload, slowing technology adoption.

Market Driver

The expansion of Decentralized and Hybrid Clinical Trials (DCTs) is a key driver for eConsent solution adoption, transforming participant engagement across diverse geographical areas. As the industry shifts from traditional site-based models, electronic consent platforms are crucial for remote enrollment and continuous compliance, eliminating the need for physical visits. This trend is reinforced by investigative sites' preference for adaptable operational models that reduce administrative tasks; a March 2024 Tufts CSDD article reported that 61.4% of sites favor hybrid or fully decentralized trial models, highlighting the indispensable role of digital tools. As a result, eConsent systems are increasingly incorporated into study protocols to connect remote participants with research investigators. Concurrently, the growing focus on patient-centricity and enhanced comprehension is propelling the market, as stakeholders seek tools that improve participants' understanding of complex medical information via interactive multimedia. Unlike static paper forms, digital platforms provide videos and layered information, empowering patients to make truly informed decisions and boosting retention. An OpenClinica article from May 2024 indicated that 61% of respondents found eConsent forms "very easy" to understand, proving their advantage over traditional methods. This user-friendly design significantly enhances the participant experience and accelerates technology adoption, with Florence Healthcare noting a threefold increase in eConsent platform usage since 2020, signifying a strong move towards digital-first engagement.

Market Challenge

A major impediment to the growth of the Global EConsent In Healthcare Market is the intricate technical challenge of integrating eConsent systems with existing research site infrastructures. Despite their design for remote enrollment, digital consent tools often struggle with seamless interoperability with legacy Electronic Health Record (EHR) systems prevalent in hospitals and clinical centers. This lack of connectivity results in considerable data silos, compelling research staff to handle fragmented workflows instead of benefiting from a unified system. Such operational friction, caused by integration failures, discourages research sites from fully embracing eConsent platforms, as the technology frequently adds complexity rather than streamlining operations. This fragmentation directly hinders market expansion by imposing excessive administrative loads on clinical trial personnel, who are required to manually bridge these technical discrepancies. In 2025, about 60% of research site staff reported frequently performing redundant data entry due to unintegrated clinical technologies, according to the Association of Clinical Research Professionals. This significant manual duplication elevates the risk of errors and diverts valuable time from patient care. Consequently, many stakeholders are reluctant to adopt standalone eConsent solutions, thereby restricting the market's broader scalability.

Market Trends

A pivotal trend is the integration of Artificial Intelligence for Patient Comprehension Analysis, moving beyond mere digital presentation to active, real-time verification of understanding. AI-driven algorithms and Natural Language Processing (NLP) now evaluate participant literacy during the consent process, dynamically simplifying complex medical terms to ensure genuinely informed decisions. This feature is becoming critical as protocols become more intricate, though the technology is still in its nascent stages of widespread adoption. An Applied Clinical Trials Online article from June 2025 noted that only 11% of approximately 80 companies fully use AI/ML in clinical trial activities, suggesting substantial growth potential as these advanced comprehension tools evolve. Concurrently, the market observes a convergence with Electronic Health Records and eClinical Systems, aiming to eliminate the operational silos that currently burden research sites. Stakeholders are actively pursuing unified ecosystems where eConsent platforms seamlessly interact with existing site technologies, enabling Single Sign-On (SSO) and automated data transfer into patient records. This trend directly addresses the excessive administrative burden imposed by fragmented systems, prompting vendors to prioritize integration over standalone offerings. The demand for operational efficiency is evident; a Greenphire survey from October 2024 revealed that 95% of sites value technology that reduces effort and time spent on tasks, thereby accelerating the adoption of these interconnected eClinical environments.

Key Market Players

• Veeva Systems Inc.
• Magentus Software Limited
• Florence Healthcare Inc.
• Concentric Health Ltd
• 5thPort, LLC
• Cloudbyz Inc.
• Calysta EMR
• Interlace Health, LLC
• Thieme Compliance GmbH
• OpenClinica, LLC

Report Scope

In this report, the Global EConsent In Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• EConsent In Healthcare Market, By Platform
• Cloud-based
• Web-based
• EConsent In Healthcare Market, By Enrollment Type
• On-site
• Remote
• EConsent In Healthcare Market, By Form Type
• General Consent
• General Consent with Specific Denial(s)
• General Denial with Specific Consent(s)
• General Denial
• EConsent In Healthcare Market, By Region
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global EConsent In Healthcare Market.

Available Customizations:

Global EConsent In Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL ECONSENT IN HEALTHCARE MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Platform (Cloud-based, Web-based)
  5.2.2. By Enrollment Type (On-site, Remote)
  5.2.3. By Form Type (General Consent, General Consent with Specific Denial(s), General Denial with Specific Consent(s), General Denial)
  5.2.4. By Region
  5.2.5. By Company (2025)
5.3. Market Map

6. NORTH AMERICA ECONSENT IN HEALTHCARE MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Platform
  6.2.2. By Enrollment Type
  6.2.3. By Form Type
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States EConsent In Healthcare Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Platform
      6.3.1.2.2. By Enrollment Type
      6.3.1.2.3. By Form Type
  6.3.2. Canada EConsent In Healthcare Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Platform
      6.3.2.2.2. By Enrollment Type
      6.3.2.2.3. By Form Type
  6.3.3. Mexico EConsent In Healthcare Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Platform
      6.3.3.2.2. By Enrollment Type
      6.3.3.2.3. By Form Type

7. EUROPE ECONSENT IN HEALTHCARE MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Platform
  7.2.2. By Enrollment Type
  7.2.3. By Form Type
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany EConsent In Healthcare Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Platform
      7.3.1.2.2. By Enrollment Type
      7.3.1.2.3. By Form Type
  7.3.2. France EConsent In Healthcare Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Platform
      7.3.2.2.2. By Enrollment Type
      7.3.2.2.3. By Form Type
  7.3.3. United Kingdom EConsent In Healthcare Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Platform
      7.3.3.2.2. By Enrollment Type
      7.3.3.2.3. By Form Type
  7.3.4. Italy EConsent In Healthcare Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Platform
      7.3.4.2.2. By Enrollment Type
      7.3.4.2.3. By Form Type
  7.3.5. Spain EConsent In Healthcare Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Platform
      7.3.5.2.2. By Enrollment Type
      7.3.5.2.3. By Form Type

8. ASIA PACIFIC ECONSENT IN HEALTHCARE MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Platform
  8.2.2. By Enrollment Type
  8.2.3. By Form Type
  8.2.4. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China EConsent In Healthcare Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Platform
      8.3.1.2.2. By Enrollment Type
      8.3.1.2.3. By Form Type
  8.3.2. India EConsent In Healthcare Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Platform
      8.3.2.2.2. By Enrollment Type
      8.3.2.2.3. By Form Type
  8.3.3. Japan EConsent In Healthcare Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Platform
      8.3.3.2.2. By Enrollment Type
      8.3.3.2.3. By Form Type
  8.3.4. South Korea EConsent In Healthcare Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Platform
      8.3.4.2.2. By Enrollment Type
      8.3.4.2.3. By Form Type
  8.3.5. Australia EConsent In Healthcare Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Platform
      8.3.5.2.2. By Enrollment Type
      8.3.5.2.3. By Form Type

9. MIDDLE EAST & AFRICA ECONSENT IN HEALTHCARE MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Platform
  9.2.2. By Enrollment Type
  9.2.3. By Form Type
  9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia EConsent In Healthcare Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Platform
      9.3.1.2.2. By Enrollment Type
      9.3.1.2.3. By Form Type
  9.3.2. UAE EConsent In Healthcare Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Platform
      9.3.2.2.2. By Enrollment Type
      9.3.2.2.3. By Form Type
  9.3.3. South Africa EConsent In Healthcare Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Platform
      9.3.3.2.2. By Enrollment Type
      9.3.3.2.3. By Form Type

10. SOUTH AMERICA ECONSENT IN HEALTHCARE MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Platform
  10.2.2. By Enrollment Type
  10.2.3. By Form Type
  10.2.4. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil EConsent In Healthcare Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Platform
      10.3.1.2.2. By Enrollment Type
      10.3.1.2.3. By Form Type
  10.3.2. Colombia EConsent In Healthcare Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Platform
      10.3.2.2.2. By Enrollment Type
      10.3.2.2.3. By Form Type
  10.3.3. Argentina EConsent In Healthcare Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Platform
      10.3.3.2.2. By Enrollment Type
      10.3.3.2.3. By Form Type

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL ECONSENT IN HEALTHCARE MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Veeva Systems Inc.
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. Magentus Software Limited
15.3. Florence Healthcare Inc.
15.4. Concentric Health Ltd
15.5. 5thPort, LLC
15.6. Cloudbyz Inc.
15.7. Calysta EMR
15.8. Interlace Health, LLC
15.9. Thieme Compliance GmbH
15.10. OpenClinica, LLC

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER